Sun Pharmaceutical Industries Limited announced that all resolutions presented at its 34th Annual General Meeting (AGM), held on July 31, 2026, have been approved by the shareholders. The company confirmed that the voting results and the scrutinizer’s report are now available on its website, signifying the successful conclusion of the meeting and the formal endorsement of the proposed agenda items.
Sun Pharma’s 34th AGM Concludes Successfully
Sun Pharmaceutical Industries Limited has formally announced the outcome of its 34th Annual General Meeting (AGM), which took place on July 31, 2026. In a significant development for the company and its stakeholders, all resolutions put forth for shareholder approval during the meeting were duly passed with the requisite majority. This successful conclusion indicates shareholder confidence and alignment with the company’s strategic direction.
Voting Results and Scrutinizer’s Report
The company has made the official voting results and the detailed report from the appointed scrutinizer publicly available. These documents, pertaining to the resolutions presented in the AGM notice dated July 6, 2026, confirm the positive outcome of the shareholder vote. The resolutions are now effective as per applicable legal provisions. Both the voting results and the scrutinizer’s report can be accessed on the company’s official website, www.sunpharma.com, ensuring transparency and compliance.
Source: BSE
